左甲状腺素治疗患者的血清促甲状腺激素和三碘甲状腺原氨酸水平
这项横断面观察性研究纳入2009年1月1日至2019年12月31日大型临床数据库中9850例18岁及以上接受左甲状腺素(LT4)治疗的患者,按血清游离甲状腺素(FT4)水平分组,拟合FT4与促甲状腺激素(TSH)、FT4与总三碘甲状腺原氨酸(T3)及FT4与T3/FT4比值的关系。结果显示FT4与T3关系在FT4 0.7 ng/dL处出现拐点后斜率变平,FT4与TSH呈两条负向S形曲线,FT4与T3/FT4呈渐近回归曲线;作者结论认为LT4剂量调整大幅改变FT4和TSH时可能仅轻微影响T3水平,无显著临床获益。
要点
- FT4与T3关系在FT4 0.7 ng/dL处出现拐点,之后斜率变平并呈凸二次曲线。
- FT4与TSH关系呈两条负向S形曲线,随FT4升高TSH陡降。
- FT4与T3/FT4关系拟合为渐近回归曲线,支持高FT4时T4向T3活化减少。
核心结论
- 在LT4治疗患者中,血清FT4与TSH及FT4与T3的关系在不同FT4水平范围内不成比例。
- 因此LT4剂量调整大幅改变血清FT4和TSH值时可能仅轻微影响血清T3水平,无显著临床获益。
研究设计与样本
- 横断面观察性研究,纳入2009年1月1日至2019年12月31日大型临床数据库中9850例18岁及以上接受LT4治疗的患者,按血清FT4水平分组。
主要发现
- FT4与T3关系在FT4 0.7 ng/dL拐点前呈线性关联,之后斜率变平并呈凸二次曲线。
- FT4与TSH关系呈两条负向S形曲线,随FT4升高TSH陡降。
- FT4与T3/FT4关系拟合为渐近回归曲线,支持较高FT4水平时T4向T3活化减少。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Small adjustments in levothyroxine (LT4) dose do not appear to provide clinical benefit despite changes in thyrotropin (TSH) levels within the reference range. We hypothesize that the accompanying changes in serum total triiodothyronine (T3) levels do not reflect the magnitude of the changes in serum TSH. OBJECTIVE: This work aims to characterize the relationships of serum free thyroxine (FT4) vs T3, FT4 vs TSH, and FT4 vs the T3/FT4 ratio. METHODS: This cross-sectional, observational study comprised 9850 participants aged 18 years and older treated with LT4 from a large clinical database from January 1, 2009, to December 31, 2019. Patients had been treated with LT4, subdivided by serum FT4 level. Main outcome measures included model fitting of the relationships between serum FT4 vs TSH, FT4 vs T3, and FT4 vs T3/FT4. Mean and median values of TSH, T3, and T3/FT4 were calculated. RESULTS: The relationships T3 vs FT4 and TSH vs FT4 were both complex and best represented by distinct, segmented regression models. Increasing FT4 levels were linearly associated with T3 levels until an inflection point at an FT4 level of 0.7 ng/dL, after which a flattening of the slope was observed following a convex quadratic curve. In contrast, increasing FT4 levels were associated with steep declines in TSH following 2 negative sigmoid curves. The FT4 vs T3/FT4 relationship was fit to an asymptotic regression curve supporting less T4 to T3 activation at higher FT4 levels. CONCLUSION: In LT4-treated patients, the relationships between serum FT4 vs TSH and FT4 vs T3 across a range of FT4 levels are disproportionate. As a result, dose changes in LT4 that robustly modify serum FT4 and TSH values may only minimally affect serum T3 levels and result in no significant clinical benefit.
引用
- Ettleson MD, Prieto WH, Russo PST, et al. Serum Thyrotropin and Triiodothyronine Levels in Levothyroxine-treated Patients. J Clin Endocrinol Metab. 2023. PMID: 36515655. doi:10.1210/clinem/dgac725
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。